Arcturus Therapeutics (ARCT) vs Galectin Therapeutics (GALT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Galectin Therapeutics is the larger company by market cap ($365.1 million vs $362.8 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ARCT | GALT |
|---|---|---|
| Share price | $12.77 | $3.62 |
| Market cap | $362.82M | $365.08M |
| 1-day change | -1.81% | -3.72% |
| YTD return | — | -12.98% |
| 1-year return | — | -24.11% |
| 5-year return | — | +7.42% |
| EPS (TTM) | $-3.33 | $-0.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.17 | $7.13 |
| 52-week low | $5.50 | $2.03 |
| Distance from 52-week high | -47.19% | -49.23% |
| Average volume | 938.70K | 387.94K |
| Shares outstanding | 28.42M | 100.85M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ARCT vs GALT FAQ
Which is bigger, Arcturus Therapeutics or Galectin Therapeutics?
Galectin Therapeutics (GALT) is larger, with a market capitalization of $365.08M compared with $362.82M for Arcturus Therapeutics (ARCT).
Are Arcturus Therapeutics and Galectin Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.